Molecular Imaging of Glial Tumors: Established and Emerging Tracers

Molecular Imaging of Glial Tumors: Established and Emerging Tracers

Various positron emission tomography (PET) tracers have been developed and extensively studied in the field of neuro-oncology imaging. In the management of brain tumors, accurate delineation of tumor extent, assessment of treatment response, and detection of early recurrence are the most important f...

Full description

Bibliographic Details
Main Authors:	Indraja D. Dev, Venkatesh Rangarajan, Nilendu C. Purandare, Ameya D. Puranik
Format:	Article
Language:	English
Published:	Thieme Medical Publishers, Inc. 2023-08-01
Series:	Indian Journal of Neurosurgery
Subjects:	FDG FET FDOPA PET/CT glioma
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0043-1770910

Similar Items

Comparing [18F]FET PET and [18F]FDOPA PET for glioma recurrence diagnosis: a systematic review and meta-analysis
by: Pengbo Yu, et al.
Published: (2024-01-01)

[18F]FDOPA PET/CT is superior to [68Ga]DOTATOC PET/CT in diagnostic imaging of pheochromocytoma
by: Peter Iversen, et al.
Published: (2023-12-01)

The Use of <sup>18</sup>F-FET-PET-MRI in Neuro-Oncology: The Best of Both Worlds—A Narrative Review
by: Tineke van de Weijer, et al.
Published: (2022-05-01)

Emerging PET Tracers in Cardiac Molecular Imaging
by: Shashi Bhushan Singh, et al.
Published: (2023-01-01)

Can Radiomics Provide Additional Information in [<sup>18</sup>F]FET-Negative Gliomas?
by: Katharina von Rohr, et al.
Published: (2022-10-01)

Hotspot on 18F-FET PET/CT to Predict Aggressive Tumor Areas for Radiotherapy Dose Escalation Guiding in High-Grade Glioma
by: Bastien Allard, et al.
Published: (2022-12-01)

FDOPA-(18F): a PET radiopharmaceutical recently registered for diagnostic use in countries of the European Union
by: Yanna-Marina Chevalme, et al.
Published: (2007-09-01)

18F-FDOPA PET/CT Combined with MRI for Gross Tumor Volume Delineation in Patients with Skull Base Paraganglioma
by: Mehdi Helali, et al.
Published: (2019-01-01)

The Utility of Conventional Amino Acid PET Radiotracers in the Evaluation of Glioma Recurrence also in Comparison with MRI
by: Giulia Santo, et al.
Published: (2022-03-01)

The role of 18F-FDG PET/CT in the management of large-vessel vasculitis: applications and limitations in clinical practice
by: Maria V. Mattoli, et al.
Published: (2012-01-01)

A Biopsy-Controlled Prospective Study of Contrast-Enhancing Diffuse Glioma Infiltration Based on FET-PET and FLAIR
by: Maciej Harat, et al.
Published: (2024-03-01)

Dynamic 18F-FET PET/CT to differentiate recurrent primary brain tumor and brain metastases from radiation necrosis after single-session robotic radiosurgery
by: Winna Lim, et al.
Published: (2022-01-01)

What Does PET Imaging Bring to Neuro-Oncology in 2022? A Review
by: Jules Tianyu Zhang-Yin, et al.
Published: (2022-02-01)

Feasibility of radiomic feature harmonization for pooling of [18F]FET or [18F]GE-180 PET images of gliomas
by: Adrian Jun Zounek, et al.
Published: (2023-02-01)

Use of PET Imaging in Neuro-Oncological Surgery
by: Adrien Holzgreve, et al.
Published: (2021-04-01)

Positron Emission Tomography Molecular Imaging of the Major Neurodegenerative Disorders: Overview and Pictorial Essay, from a Nuclear Medicine Center's Perspective
by: Ferdinando Calabria, et al.
Published: (2023-12-01)

Tumor Glucose Metabolism and Its Heterogeneity on F-18 FDG PET/CT Provide Better Prognostication in Nonmetastatic Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma
by: Hojin Cho, et al.
Published: (2021-11-01)

A Retrospective Analysis of the Most Common Bone Metastases of Various Malignant Tumors with Cross-sectional Imaging and 18-FDG-PET/CT Data
by: Mehmet Öncü, et al.
Published: (2022-03-01)

Diagnostic Performance of Dynamic Whole-Body Patlak [<sup>18</sup>F]FDG-PET/CT in Patients with Indeterminate Lung Lesions and Lymph Nodes
by: Matthias Weissinger, et al.
Published: (2023-06-01)

The role of 18F-FDG PET/CT in evaluation of Primary CNS lymphoma: The path less travelled
by: Sharjeel Usmani, et al.
Published: (2023-07-01)

Role of 18F FDG PET/CT in evaluation of post-operative ovarian carcinoma
by: Marwa Ibrahim El-Sayed Amer, et al.
Published: (2022-09-01)

The place of <sup>18</sup>F FDG PET/CT in the management of patients with eosinophilic fasciitis: a case report
by: N. Belfeki, et al.
Published: (2021-01-01)

Glucose Loading Enhances the Value of <sup>18</sup>F-FDG PET/CT for the Characterization and Delineation of Cerebral Gliomas
by: Dongwoo Kim, et al.
Published: (2020-07-01)

Differential Spatial Distribution of TSPO or Amino Acid PET Signal and MRI Contrast Enhancement in Gliomas
by: Lena Kaiser, et al.
Published: (2021-12-01)

Scope of PET imaging in the evaluation of cardiac tumors
by: Sanchay Jain, et al.
Published: (2023-01-01)

Concomitant Prostate Cancer and Hodgkin Lymphoma: A Differential Diagnosis Guided by a Combined 68Ga-PSMA-11 and 18F-FDG PET/CT Approach
by: Alberto Miceli, et al.
Published: (2021-09-01)

Positron Emission Tomography in Breast Cancer
by: Jose Luis Vercher-Conejero, et al.
Published: (2015-03-01)

A novel semiautomated method for background activity and biological tumour volume definition to improve standardisation of 18F-FET PET imaging in glioblastoma
by: Caterina Brighi, et al.
Published: (2022-02-01)

The Role of Positron Emission Tomography- Computed Tomography/Magnetic Resonance Imaging in Modern Medicine
by: Sina Houshmand, et al.
Published: (2014-09-01)

<sup>18</sup>F-FET PET Uptake Characteristics of Long-Term IDH-Wildtype Diffuse Glioma Survivors
by: Lena M. Mittlmeier, et al.
Published: (2021-06-01)

Noninvasive Delineation of Glioma Infiltration with Combined 7T Chemical Exchange Saturation Transfer Imaging and MR Spectroscopy: A Diagnostic Accuracy Study
by: Yifan Yuan, et al.
Published: (2022-09-01)

Validation of image-derived input function using a long axial field of view PET/CT scanner for two different tracers
by: Xavier Palard-Novello, et al.
Published: (2024-03-01)

Comparison of conventional and Si-photomultiplier-based PET systems for image quality and diagnostic performance
by: Jenny Oddstig, et al.
Published: (2019-10-01)

The Value of Semiquantitative Parameters Derived from <sup>18</sup>F-FDG PET/CT for Predicting Response to Neoadjuvant Chemotherapy in a Cohort of Patients with Different Molecular Subtypes of Breast Cancer
by: Luca Urso, et al.
Published: (2022-11-01)

Captación ganglionar axilar en PET/CT con 18F-FDG como hallazgo incidental por vacuna COVID-19
by: David R. Cardoza-Ochoa, et al.
Published: (2024-01-01)

Impact of [<sup>18</sup>F]FDG PET/CT in the Assessment of Immunotherapy-Induced Arterial Wall Inflammation in Melanoma Patients Receiving Immune Checkpoint Inhibitors
by: Shaghayegh Ranjbar, et al.
Published: (2023-05-01)

[18F]FDG-PET/CT Radiomics for Prediction of Bone Marrow Involvement in Mantle Cell Lymphoma: A Retrospective Study in 97 Patients
by: Marius E. Mayerhoefer, et al.
Published: (2020-05-01)

State of the Art in 2022 PET/CT in Breast Cancer: A Review
by: Jules Zhang-Yin
Published: (2023-01-01)

Use of 18F‐2‐deoxy‐2‐fluoro‐D‐glucose positron emission tomography/computed tomography for staging thyroid carcinoma in a cat
by: Seonggweon Kang, et al.
Published: (2023-05-01)

The significance of positron emission and computerized tomography with fluorodeoxyglucose in the post-therapeutic evaluation of patients with uterine carcinoma
by: Jelić Ivona, et al.
Published: (2019-01-01)